Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial
Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial
复制标题
DOI:
10.1136/bmj.331.7519.723
复制
发表时间:
2005-10-01
影响因子:
105.7
通讯作者:
Aaby, P
中科院分区:
文献类型:
--
作者:
Hoj, L;Cardoso, P;Aaby, P
Objective To evaluate whether routine administration of sublingual misoprostol 600 mu g after delivery reduces postpartum haemorrhage.Design Randomised double blind placebo controlled trial.Setting Primary health centre in Bissau, Guinea-Bissau, West Africa.Participants 661 women undergoing vaginal delivery.Intervention Misoprostol 600 mu g or placebo administered sublingually immediately after delivery.Main outcome measures Postpartum haemorrhage, defined as a loss of >= 500 ml and decrease in haemoglobin concentration after delivery.Results The incidence of postpartum haemorrhage was not significantly different between the two groups, the relative risk being 0.89 (95% confidence interval 0.76 to 1.04) in the misoprostol group compared with the placebo group. Mean blood loss was 10.5% (- 0.5% to 20.4%) lower in the misoprostol group than in the control group. Severe postpartum haemorrhage of >= 1000 ml or >= 1500 ml occurred in 17% (56) and 8% (25) in the placebo group and 11% (37) and 2% (7) in the misoprostol group. Significantly fewer women in the misoprostol group experienced a loss of >= 1000 ml (0.66,0.45 to 0.98) or >= 1500 ml (0.28, 0.12 to 0.64). The decrease in haemoglobin concentration tended to be less in the misoprostol group, the mean difference between the two groups being 0.16 mmol/l (- 0.01 mmol/l to 0.32 mmol/l).Conclusion Sublingual misoprostol reduces the frequency of severe postpartum haemorrhage.